• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Med (Lond) . SARS-CoV-2 antibody seroprevalence in NHS healthcare workers in a large double-sited UK hospital

tetano

Editor, Senior Moderator
Clin Med (Lond)


. 2021 Mar 23;clinmed.2020-1096.
doi: 10.7861/clinmed.2020-1096. Online ahead of print.
SARS-CoV-2 antibody seroprevalence in NHS healthcare workers in a large double-sited UK hospital


Gie Ken-Dror[SUP] 1 [/SUP], Charles Wade[SUP] 2 [/SUP], Shyam S Sharma[SUP] 3 [/SUP], Melanie Irvin-Sellers[SUP] 4 [/SUP], Jonathan Robin[SUP] 4 [/SUP], David Fluck[SUP] 4 [/SUP], Paul Bentley[SUP] 5 [/SUP], Pankaj Sharma[SUP] 6 [/SUP]



Affiliations

Abstract

We determined the seroprevalence of SARS-CoV-2 antibodies in NHS healthcare workers (HCWs) in a cross-sectional study from a large general hospital located in a double-sited rural and semi-rural area. The sample size of 3,119 HCWs (mean age 43?13) consisted of 75.2% women, 61.1% White individuals and predominantly (62.4%) asymptomatic individuals. Seroprevalence of SARS-CoV-2 antibodies was 19.7%. Determinants of seropositivity were preceding symptomatic infection and non-White ethnicity. Regardless of staff role or sex, multivariate regression analysis revealed that non-White HCWs were three times (odds ratio [OR] 3.12, 95% confidence interval [CI] 2.53-3.86, P<0.001) more likely to have antibodies than White staff, and seven times (OR 7.10, 95% CI 5.72-8.87, P<0.001) more likely if there was a history of preceding symptoms. We report relatively high rates of seropositivity in all NHS healthcare workers. Non-White symptomatic HCWs were significantly more likely to be seropositive than their colleagues, independent of age, sex or staff role.

Keywords: COVID-19; NHS staff; SARS-CoV-2; antibody; coronavirus; healthcare workers; seropositive.
 
Back
Top Bottom